The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.

Enable Injections announced today that it received a commitment from Sanofi for a $30 million investment to drive growth.

Subcutaneous anifrolumab significantly reduces disease activity in patients with moderate to severe systemic lupus erythematosus.

Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research indicates for men evaluating prescription testosterone pathways heading into ...

It is expected that Herjuema, Celltrion's anticancer drug, will be able to be administered as a subcutaneous (SC) injection in under five minutes. Celltrion said on Dec. 8 that it plans to submit ...

Testosterone therapy costs vary widely depending on the formulation you use, with injections generally the most affordable and pellets the most expensive. Even if insurance covers your testosterone ...

In the U.S., testosterone is a controlled substance, so you’ll need a prescription to acquire it. While you take it, your provider will order blood tests and monitor you closely to ensure treatment is ...

Excess belly fat poses serious health risks, including diabetes and heart disease. The article distinguishes between subcutaneous fat under the skin and dangerous visceral fat surrounding organs.

Annalisa (Nalis) Merelli is a contributing writer at STAT focused on boys’ and men’s health. Increased physical stamina. “Facility of intellectual labour.” A longer jet of urine. These were some of ...

Compared with placebo, significantly greater proportions of patients treated with Tremfya achieved clinical remission and endoscopic improvement. HealthDay News — The US Food and Drug Administration ...

The FDA has approved Merck & Co.’s under-the-skin version of Keytruda, reducing treatment time burden for patients while granting the world’s bestselling drug potential blockbuster revenue protection.

Please provide your email address to receive an email when new articles are posted on . Leqembi Iqlik is the first approved in-home anti-amyloid injectable for early Alzheimer’s disease. Patients ...